Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

ELDN holding history

Eledon Pharmaceuticals, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ELDN overviewAll 13F holders of ELDNFull Q2 2026 holdings

Shares (Q2 2026)
1,048,245
Value
$4.13M
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of ELDN by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,048,245$4.13M<0.1%+500,798+91.5%AddedHolders
Q1 2026547,447$1.69M<0.1%−45,684−7.7%ReducedHolders
Q4 2025593,131$895.6K<0.1%+499,678+534.7%AddedHolders
Q3 202593,453$242.0K<0.1%−32,813−26.0%ReducedHolders
Q2 2025126,266$342.2K<0.1%+103,041+443.7%AddedHolders
Q1 202523,225$78.7K<0.1%−295,356−92.7%ReducedHolders
Q4 2024318,581$1.31M<0.1%+318,577+7,964,425.0%AddedHolders
Q3 20244$10<0.1%−54,997−100.0%ReducedHolders
Q2 202455,001$145.2K<0.1%+54,997+1,374,925.0%AddedHolders
Q1 20244$8<0.1%−552−99.3%ReducedHolders
Q4 2023556$1.00K<0.1%+556NewHolders
Q3 20230$00.0%−32−100.0%Sold outHolders
Q2 202332$44<0.1%−424−93.0%ReducedHolders
Q1 2023456$1.08K<0.1%−3,536−88.6%ReducedHolders
Q4 20223,992$9.10K<0.1%+2,978+293.7%AddedHolders
Q3 20221,014$3.00K<0.1%−3,624−78.1%ReducedHolders
Q2 20224,638$11.0K<0.1%+4,638NewHolders
Q1 20220$00.0%−3,638−100.0%Sold outHolders
Q4 20213,638$16.0K<0.1%+3,583+6,514.5%AddedHolders
Q3 202155$00.0%00.0%UnchangedHolders
Q2 202155$00.0%00.0%UnchangedHolders
Q1 202155$1.00K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.